Knight Therapeutics Inc.
OTC: KHTRF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Samira Sakhia
- Employees
- 745
- Headquarters
- Montreal, Canada
- IPO year
- 2014
- Market cap
- $643.7M
- Website
- https://www.gud-knight.com
Loading KHTRF…
Loading profile data…Frequently asked questions about KHTRF
What does Knight Therapeutics Inc. (KHTRF) do?
Knight Therapeutics Inc. operates as a specialized pharmaceutical enterprise, actively engaged in the development, acquisition, in-licensing, out-licensing, marketing, and distribution of a broad spectrum of pharmaceutical goods, consumer health solutions, and medical devices. Its operational footprint extends across Canada, Latin America, and o...
Where does KHTRF trade?
Knight Therapeutics Inc. (KHTRF) trades on the Other OTC.
What sector is KHTRF in?
Knight Therapeutics Inc. (KHTRF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Knight Therapeutics Inc.?
Samira Sakhia is the chief executive officer of Knight Therapeutics Inc. (KHTRF).
Where is Knight Therapeutics Inc. headquartered?
Knight Therapeutics Inc. is headquartered in Canada.
Does KHTRF pay a dividend?
Knight Therapeutics Inc. (KHTRF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KHTRF go public?
Knight Therapeutics Inc. (KHTRF) completed its initial public offering in 2014.